Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Tranexamic Acid and 1927 nm Laser for Melasma
NCT03686787Phase 4Unknown
- Sponsor
- Laser & Skin Surgery Center of New York
- Start
- Oct 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tranexamic acid in melasma (2 arms), sponsored by Laser & Skin Surgery Center of New York. Primary endpoint: Modified Melasma Area and Severity Index at 16 weeks. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on NCT03686787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03686787.